Aug 8, 2025 09:38AM
Aug 8, 2025 07:15AM
May 13, 2025 06:25AM
May 13, 2025 04:52AM
May 12, 2025 07:00AM
Apr 2, 2025 07:04AM
Feb 28, 2025 07:00AM Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Feb 20, 2025 08:42AM
Nov 8, 2024 07:00AM
Aug 9, 2024 08:29AM
Aug 9, 2024 07:00AM
May 16, 2024 10:00PM
May 13, 2024 06:29AM
May 10, 2024 07:00AM Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Feb 29, 2024 07:00AM
Nov 13, 2023 07:39AM
Nov 13, 2023 07:00AM
Aug 11, 2023 06:36AM
Aug 11, 2023 06:00AM
May 15, 2023 07:00AM
Mar 17, 2023 07:00AM Akero Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 17, 2023 07:00AM
Nov 7, 2022 07:30AM
Nov 7, 2022 07:30AM
Nov 4, 2022 07:00AM
Nov 4, 2022 07:00AM
Aug 4, 2022 04:05PM
Aug 4, 2022 04:05PM Akero Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Jun 16, 2022 07:01AM
Jun 16, 2022 07:00AM
Jun 16, 2022 07:00AM
May 6, 2022 07:00AM
May 6, 2022 07:00AM
Feb 25, 2022 07:00AM
Feb 25, 2022 07:00AM Akero Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Nov 12, 2021 07:00AM
Nov 12, 2021 07:00AM
Aug 13, 2021 07:00AM
Aug 13, 2021 07:00AM
May 13, 2021 07:00AM
May 13, 2021 07:00AM
Mar 23, 2021 08:02AM Akero Therapeutics (AKRO) Announces First Patient Randomized for Dosing in Phase 2b Study of Efruxifermin in F2/F3 NASH Patients
Mar 23, 2021 08:00AM
Mar 23, 2021 08:00AM
Mar 22, 2021 04:03PM
Mar 22, 2021 04:01PM
Mar 22, 2021 04:01PM
Mar 16, 2021 08:00AM
Mar 16, 2021 08:00AM Akero Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
Nov 12, 2020 04:05PM

1,197,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All